News Corporation NWSA Gains 118 Support Holds at 2492 20260518 North NRT Q2 2025 In Line Whats Next for Investors Dallas Luxury Housing Market Shows Resilience Amid Economic Uncertainty Says Allie Beth Allman CEO Cardlytics CDLX Crushes Q1 2026 Estimates EPS 011 Tops Views Singapore Emerges as Key Safe Haven as Wealthy Flee Gulf Turmoil Reservoir Media RSVR Stalls at 1016 Consolidation Phase 20260520 Fusion HTOO Q4 2021 Earnings Beat Revenue NA EPS 6405 Lakeland LKFN Delivers Q1 2026 Beat EPS 104 vs 103 Expected Morgan Stanley Maintains Bullish Stance on NextEra Energy Despite Price Target Adjustment PROCEPT BioRobotics Receives Analyst Upgrade Following Strong Fiscal Q1 Performance European Officials See Extended Energy Price Pressures Through 2027 GLP1 Weight Loss Drug Costs Drive Higher CoPays Across Insurance Plans US Banking Sector Posts Profit Increase in First Quarter FDIC Data Shows US Pressure Campaign Against Cuba May Signal Heightened Geopolitical Risks PHR Q1 2026 Earnings EPS Beats Estimates by Wide Margin Stock Rises 2 Ingredion Q1 2026 Earnings EPS Misses Estimates Amid Challenging Operating Environment TOMI Environmental Solutions Inc Q1 2026 Earnings NarrowerThanExpected Loss Drives Stock Gain Transocean Q1 2026 Earnings Earnings Miss Estimates Amid Challenging Offshore Market TransMedics Q1 2026 Earnings EPS Misses Estimates by 52 as Revenue Data Unavailable Global Markets Eye Potential TrumpXi Summit Outcomes as Trade Tensions Simmer LPLA Q1 2026 Earnings Marginal EPS Beat Meets a Cautious Market HMC Q1 2026 Earnings Significant Loss Per Share Exceeds Estimates Veris Residential Inc VRE Q4 2025 Earnings Narrowing Losses and a Slight Market Uptick MGM Q1 2026 Earnings EPS Misses Estimates Amidst Operational Pressures Tiptree Inc TIPT Q2 2025 Earnings Solid EPS Performance Despite Revenue Opacity Blackbaud BLKB Q1 2026 Earnings Slight EPS Beat Drives Modest Share Gain SRE Q1 2026 Earnings Slight EPS Miss as Utility Performance Holds Steady Lyell Immunopharma LYEL Q1 2026 Earnings Narrower Loss Beats Estimates as Biotech Advances Pipeline